• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

京都大学iPS细胞种子库(京都大学iPS细胞库存项目)

CiRA iPSC seed stocks (CiRA's iPSC Stock Project).

作者信息

Hanatani Tadaaki, Takasu Naoko

机构信息

Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.

Center for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan.

出版信息

Stem Cell Res. 2020 Oct 9;50:102033. doi: 10.1016/j.scr.2020.102033.

DOI:10.1016/j.scr.2020.102033
PMID:33445065
Abstract

In Japan, induced pluripotent stem cell (iPSC) Stock Project has started from 2013. The goal of the Project is to manufacture and release clinical-grade HLA homozygous iPSC lines that can cover almost the entire of Japanese population. We show the summary of the cell lines distributed, test results for quality control and future plans.

摘要

在日本,诱导多能干细胞(iPSC)储备项目自2013年启动。该项目的目标是制造并发布临床级别的HLA纯合iPSC系,这些细胞系能够覆盖几乎全部的日本人口。我们展示了已分发细胞系的概要、质量控制测试结果以及未来计划。

相似文献

1
CiRA iPSC seed stocks (CiRA's iPSC Stock Project).京都大学iPS细胞种子库(京都大学iPS细胞库存项目)
Stem Cell Res. 2020 Oct 9;50:102033. doi: 10.1016/j.scr.2020.102033.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications.诱导多能干细胞(iPSCs):诱导的分子机制与应用。
Signal Transduct Target Ther. 2024 Apr 26;9(1):112. doi: 10.1038/s41392-024-01809-0.
4
Modeling rare genetic disease with patient-derived induced pluripotent stem cells: reassessment of the minimum numbers of lines needed.利用患者来源的诱导多能干细胞对罕见遗传病进行建模:重新评估所需的最小细胞系数量。
Stem Cells Transl Med. 2025 Jul 24;14(8). doi: 10.1093/stcltm/szaf032.
5
Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions.用于心律失常建模的人诱导多能干细胞衍生心肌细胞(iPSC-CMs):优势、挑战及潜在解决方案
Front Physiol. 2024 Sep 12;15:1475152. doi: 10.3389/fphys.2024.1475152. eCollection 2024.
6
Derivation of trophoblast stem cells from naïve human pluripotent stem cells.从原始人多能干细胞中衍生滋养层干细胞。
Elife. 2020 Feb 12;9:e52504. doi: 10.7554/eLife.52504.
7
EFFECTS OF BACTERIAL LIPOPOLYSACCHARIDE AND SHIGA TOXIN ON INDUCED PLURIPOTENT STEM CELL-DERIVED MESENCHYMAL STEM CELLS.细菌脂多糖和志贺毒素对诱导多能干细胞衍生间充质干细胞的影响。
Shock. 2023 Jun 1;59(6):941-947. doi: 10.1097/SHK.0000000000002126. Epub 2023 Apr 11.
8
Clinical exome analysis and targeted gene repair of the c.1354dupT variant in iPSC lines from patients with PROM1-related retinopathies exhibiting diverse phenotypes.从表现出不同表型的 PROM1 相关视网膜病变患者的 iPSC 系中进行临床外显子组分析和靶向基因修复 c.1354dupT 变异。
Stem Cell Res Ther. 2024 Jul 2;15(1):192. doi: 10.1186/s13287-024-03804-2.
9
Induced pluripotent stem cell models as a tool to investigate and test fluid biomarkers in Alzheimer's disease and frontotemporal dementia.诱导多能干细胞模型作为一种研究和测试阿尔茨海默病和额颞叶痴呆液生物标志物的工具。
Brain Pathol. 2024 Jul;34(4):e13231. doi: 10.1111/bpa.13231. Epub 2024 Jan 21.
10
Use of constitutive and inducible oncogene-containing iPSCs as surrogates for transgenic mice to study breast oncogenesis.使用含有组成性和诱导性癌基因的诱导多能干细胞作为转基因小鼠的替代品,用于研究乳腺癌发生。
Stem Cell Res Ther. 2021 May 27;12(1):301. doi: 10.1186/s13287-021-02285-x.

引用本文的文献

1
A comprehensive analysis of induced pluripotent stem cell (iPSC) production and applications.诱导多能干细胞(iPSC)生成与应用的综合分析。
Front Cell Dev Biol. 2025 May 8;13:1593207. doi: 10.3389/fcell.2025.1593207. eCollection 2025.
2
Current Landscape of iPSC Haplobanks.iPSC 单倍型库的现状。
Stem Cell Rev Rep. 2024 Nov;20(8):2155-2164. doi: 10.1007/s12015-024-10783-7. Epub 2024 Sep 14.
3
Atelocollagen supports three-dimensional culture of human induced pluripotent stem cells.去端胶原蛋白支持人诱导多能干细胞的三维培养。
Mol Ther Methods Clin Dev. 2024 Jul 20;32(3):101302. doi: 10.1016/j.omtm.2024.101302. eCollection 2024 Sep 12.
4
Innovations in bio-engineering and cell-based approaches to address immunological challenges in islet transplantation.生物工程和基于细胞的方法创新,以解决胰岛移植中的免疫挑战。
Front Immunol. 2024 Apr 8;15:1375177. doi: 10.3389/fimmu.2024.1375177. eCollection 2024.
5
Evaluation of Pancreatic β-cell Differentiation Efficiency of Human iPSC Lines for Clinical Use.评估人诱导多能干细胞系用于临床的胰腺β细胞分化效率。
Curr Stem Cell Res Ther. 2024;19(11):1449-1460. doi: 10.2174/011574888X267226231126185532.
6
ROR2 expression predicts human induced pluripotent stem cell differentiation into neural stem/progenitor cells and GABAergic neurons.ROR2 表达预测人类诱导多能干细胞向神经干细胞/祖细胞和 GABA 能神经元分化。
Sci Rep. 2024 Jan 6;14(1):690. doi: 10.1038/s41598-023-51082-4.
7
Mini-TCRs: Truncated T cell receptors to generate T cells from induced pluripotent stem cells.微型T细胞受体:用于从诱导多能干细胞生成T细胞的截短型T细胞受体。
Mol Ther Methods Clin Dev. 2023 Sep 16;31:101109. doi: 10.1016/j.omtm.2023.101109. eCollection 2023 Dec 14.
8
Potency assays and biomarkers for cell-based advanced therapy medicinal products.基于细胞的治疗性药物产品的效价测定和生物标志物。
Front Immunol. 2023 Jun 9;14:1186224. doi: 10.3389/fimmu.2023.1186224. eCollection 2023.
9
Current status and prospects of regenerative medicine for spinal cord injury using human induced pluripotent stem cells: a review.利用人类诱导多能干细胞治疗脊髓损伤的再生医学现状与前景:综述
Stem Cell Investig. 2023 Mar 10;10:6. doi: 10.21037/sci-2022-037. eCollection 2023.
10
Clinical Trials of Stem Cell Therapy in Japan: The Decade of Progress under the National Program.日本干细胞疗法的临床试验:国家项目下的十年进展
J Clin Med. 2022 Nov 28;11(23):7030. doi: 10.3390/jcm11237030.